Aeglea BioTherapeutics, Inc. Gains 20.93%

Thu, Jul 06, 2023 at 07:33 PM
Aeglea BioTherapeutics, Inc. Gains 20.93%

Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) soared at $0.52, representing a gain of 20.9%. On Thu, Jul 06, 2023, AGLE:NASDAQ touched a New 2-Week High of $0.52. The stock got featured on our News Catalysts scanner on Fri, Jun 23, 2023 at 04:54 PM in the 'PRIVATE PLACEMENT' category. From Thu, Jun 22, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days

The stock spiked on Thu, Jun 22, 2023 at $0.96 with a volume of 255M+.

About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.